作者 Lu, Shanfa
期刊 CRITICAL REVIEWS IN PLANT SCIENCES , MAY 4 2021,3:40
DOI 10.1080/07352689.2021.1935719
摘要 Salvia miltiorrhiza is one of the most well known species in the genus Salvia of the Lamiaceae with great economic, academic and medicinal value. It was recorded as a traditional Chinese medicine material first in about the second century BC and later in many other ancient books. Salvia miltiorrhiza can be clinically used alone or mixed with other herbs to treat heart and cardiovascular diseases and is beneficial for management of many other diseases. In the last 30 years, S. miltiorrhiza has been studied intensively as a model system for medicinal plant biology. With the available of whole genome sequence of four S. miltiorrhiza lines and a large number of transcriptome, sRNAome and metabolome data, great progresses have been made in biosynthesis and regulatory mechanisms of bioactive compounds, such as tanshinones, phenolic acids, flavonoids, and prenylquinones. In this review, the recent results in the biosynthetic pathways of bioactive compounds in S. miltiorrhiza were summarized. The effects of biotic and abtiotic factors, plant hormones, transcription factors and noncoding RNAs on bioactive compound biosynthesis were overviewed. The mechanism of cross-talk and coordination among different biosynthetic pathways and the progress of metabolic engineering and synthetic biology for various bioactive compounds are also reviewed and discussed.
版权所有 Copyright © 2002-2025 中国科学院昆明植物研究所,All Rights Reserved 【滇ICP备05000394号】
地址:中国云南省昆明市蓝黑路132号 邮政编码:650201 点击这里联系我们